Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,047 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,047 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,047 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,047 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,047 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,047 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,047 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
20 Feb 2026
Ernest S Rady Executive Chairman · indirect
Bought
$68.34K 3,528 at 19.37
0.0%
20 Feb 2026
Jeffrey Alan Jones Chief Medical Officer
Sold at will
$67.85K 4,982 at 13.62
2.9%
Not planned
20 Feb 2026
Brandon John Moore President, COO, and Secretary
Sold on a plan
$66.11K 1,376 at 48.05
0.5%
Planned (10b5-1)
20 Feb 2026
Fred L Drake Executive Chairman · indirect
Sold at will
$64.58K 2,258 at 28.60
3.5%
Not planned
20 Feb 2026
Eric Duane Foster Chief Commercial Officer
Sold at will 4×
$61.03K 10,439 at 5.85
2.4%
Not planned
20 Feb 2026
Mike Kelliher See Remarks
Sold at will 3×
$56.10K 9,595 at 5.85
2.6%
Not planned
20 Feb 2026
Jacquelyn L Sumer Chief Legal Officer
Sold at will
$50.97K 3,742 at 13.62
2.8%
Not planned
20 Feb 2026
Bruce K Posey Chief Legal Officer
Sold on a plan 3×
$49.95K 481 at 103.85
0.7%
Planned (10b5-1)
20 Feb 2026
Eric J Downing Exec VP and COO
Sold at will
$49.31K 1,418 at 34.78
2.5%
Not planned
20 Feb 2026
Laura A Williams See Remarks
Sold at will 2×
$47.80K 8,176 at 5.85
1.8%
Not planned
20 Feb 2026
Michael Eugene Lee SVP & Chief Regulatory Officer · indirect
Sold at will
$47.16K 1,200 at 39.30
3.3%
Not planned
20 Feb 2026
Christopher Bohrson Sr VP & Chief Customer Officer
Sold on a plan
$30.23K 1,000 at 30.23
0.6%
Planned (10b5-1)
20 Feb 2026
Joseph James Reilly See Remarks
Sold at will 3×
$29.18K 4,991 at 5.85
3.2%
Not planned
20 Feb 2026
Nadia Waheed Chief Medical Officer
Sold on a plan
$27.17K 3,510 at 7.74
1.1%
Planned (10b5-1)
20 Feb 2026
David Marshall Wright VP, Corp. Controller & CAO
Sold at will
$26.44K 264 at 100.17
2.8%
Not planned
20 Feb 2026
Robert R Chapman President
Bought
$25.07K 1,200 at 20.89
1.0%
20 Feb 2026
John J. Addington Wilson Chief Operating Officer
Sold at will
$21.20K 5,403 at 3.92
1.6%
Not planned
20 Feb 2026
Austin M Woffinden EVP, Corp. Ops & Strategy
Sold on a plan
$20.56K 263 at 78.16
1.3%
Planned (10b5-1)
20 Feb 2026
Natalia Mirgorodskaya See Remarks
Sold at will
$18.92K 633 at 29.90
2.4%
Not planned
20 Feb 2026
Stas R Wolak EVP Chief Retail Banking Ofc.
Sold at will
$18.78K 430 at 43.67
10.6%
Not planned
20 Feb 2026
John E Bishop See Remarks
Sold at will 3×
$18.59K 3,179 at 5.85
0.9%
Not planned
20 Feb 2026
James Parker Brady Chief Human Resources Officer
Sold at will 2×
$14.87K 2,543 at 5.85
1.0%
Not planned
20 Feb 2026
Alison Sasser SVP - Chief Accounting Officer
Sold on a plan
$12.35K 158 at 78.16
1.8%
Planned (10b5-1)
20 Feb 2026
Scott Darling Chief Legal Officer · indirect
Sold on a plan
$11.80K 390 at 30.25
1.2%
Planned (10b5-1)
20 Feb 2026
Jason D. Arbuckle SVP - Controller
Sold at will
$11.74K 190 at 61.77
3.5%
Not planned
20 Feb 2026
Matthew Tappin President, Software Products
Sold at will
$4.17K 366 at 11.40
14.1%
Not planned
20 Feb 2026
Kelly F. Goodman See Remarks
Sold at will
$3.49K 2,269 at 1.54
1.0%
Not planned
20 Feb 2026
Murray Stahl President/Co-Portfolio Manager · indirect
Bought 6×
$2.20K 774 at 2.84
0.2%
20 Feb 2026
Murray Stahl President/Co-Portfolio Manager
Bought
$1.02K 360 at 2.84
0.2%
20 Feb 2026
Peter Doyle Co-Portfolio Manager
Bought
$556.00 200 at 2.78
40.0%
+40% of stake
19 Feb 2026
Frank Torti President and Vant Chair
Sold on a plan
$38.39M 1,400,000 at 27.42
9.2%
Planned (10b5-1)
19 Feb 2026
Alan S McKim Exec Chair, CTO. · indirect
Sold at will
$28.11M 100,000 at 281.14
4.2%
Not planned
19 Feb 2026
Amit Sachdev EVP Chief Patient & Ext Af Off
Sold on a plan 8×
$27.48M 58,613 at 468.83
49.9%
Planned (10b5-1)
19 Feb 2026
David S Congdon Executive Chairman · indirect
Sold at will 2×
$10.13M 52,000 at 194.77
6.8%
Not planned
19 Feb 2026
Joseph Molluso Co-President & Co-COO
Sold at will
$7.78M 200,000 at 38.88
38.0%
Not planned
19 Feb 2026
John S. Sensing President, Global SCS & DTS
Sold at will 8×
$6.64M 30,110 at 220.36
38.0%
Not planned
19 Feb 2026
Michelle Zatlyn President and Board Co-Chair · indirect
Sold on a plan 10×
$6.57M 35,080 at 187.39
50.4%
Sold half or more
19 Feb 2026
Harry Skip Kiil EVP & President Cardiovascular
Sold at will 5×
$5.13M 52,524 at 97.71
61.6%
Sold half or more
19 Feb 2026
Raymond Joabar Grp. Pres., Global Comm. Serv.
Sold at will 4×
$4.77M 14,000 at 340.67
61.7%
Sold half or more
19 Feb 2026
Paul A Mahon EVP & General Counsel
Sold on a plan 8×
$3.95M 8,300 at 476.34
18.4%
Planned (10b5-1)
19 Feb 2026
Diana B Sorfleet EVP & CAO
Sold at will
$3.74M 90,000 at 41.56
35.2%
Not planned
19 Feb 2026
Ramsaran Maharajh EVP and General Counsel
Sold at will
$3.10M 15,124 at 204.65
53.4%
Sold half or more
19 Feb 2026
William Clay Ford Jr Executive Chair and Chair · indirect
Bought
$1.93M 140,000 at 13.82
3.7%
First buy in 3+ yrs
19 Feb 2026
Pablo J Cagnoni President, R&D
Sold on a plan
$1.88M 18,668 at 100.91
7.4%
Planned (10b5-1)
19 Feb 2026
Christopher Scott Edmonds President, Fixed Income & Data
Sold on a plan 4×
$1.74M 11,303 at 153.82
44.2%
Planned (10b5-1)
19 Feb 2026
Mojgan M Lefebvre EVP & Chief Tech & Ops Officer
Sold at will
$1.74M 5,827 at 298.25
100%
Sold half or more
19 Feb 2026
Dana Aftab EVP, Research and Development
Sold at will
$1.32M 29,873 at 44.35
4.3%
Not planned
19 Feb 2026
Rajeev Menon President, APEC
Sold at will
$1.24M 3,492 at 354.00
36.8%
Not planned
19 Feb 2026
Joseph D Mansueto Executive Chairman
Sold on a plan 2×
$1.17M 7,250 at 161.87
0.1%
Planned (10b5-1)
19 Feb 2026
Frank C Orsini EVP and President, Seating
Sold at will
$1.14M 8,354 at 136.14
25.9%
Not planned
Showing 16,551–16,600 of 23,047. ← Newer Page 332 of 461 Older →